Home LiteratureArticle Details
PMID: 1420999 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Regulation of synovial cell growth: basic fibroblast growth factor synergizes with interleukin 1 beta stimulating phospholipase A2 enzyme activity, phospholipase A2 activating protein production and release of prostaglandin E2 by rheumatoid arthritis synovial cells in culture.

Cytokine ·Vol. 4 ·No. 5 ·1992-09-00 ·Pages 377-84

Goddard DH, Grossman SL, Newton R, Clark MA, Bomalaski JS

Abstract

Cytokines have been implicated in the regulation of eicosanoid synthesis and synovial cell proliferation. To further define these mechanisms, we have compared the effects of basic fibroblast growth factor and platelet-derived growth factor on cell growth, prostaglandin E2 (PGE2) production and phospholipase A2 enzyme activity in long-term cultures of synovial cells from rheumatoid arthritis (RA) patients capable of proliferating in serum-free medium. Compared with serum-free medium alone, RA synovial cell growth was significantly enhanced by adding either basic fibroblast growth factor (bFGF) or platelet-derived growth factor (PDGF) to the culture medium. Growing RA synovial cells for 14 days in serum-free medium plus bFGF caused them to spontaneously release significant amounts of PGE2, an effect not seen if cells were grown in serum-free medium alone, or serum-free medium plus PDGF. Enhanced release of PGE2 occurred when arachidonic acid was added to bFGF but not PDGF-treated RA synovial cells, suggesting that bFGF increased cyclooxygenase enzyme activity in these cells. Moreover, phospholipase A2 (PLA2) enzyme activity was found to be significantly greater in RA synovial cells grown for 14 days in serum-free medium containing bFGF alone, or bFGF plus interleukin 1 beta (IL-1 beta) compared with cells grown in either serum-free medium alone, or serum-free medium plus PDGF. Similarly, bFGF plus IL-1 beta-stimulated release of PLA2 activating protein, a novel mammalian phospholipase stimulator found in high concentrations in RA synovial fluid.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Arthritis, Rheumatoid/pathology,physiopathology Cell Division/drug effects Cells, Cultured Dinoprostone/metabolism Drug Synergism Enzyme Activation/drug effects Fibroblast Growth Factor 2/administration & dosage Humans In Vitro Techniques Interleukin-1/administration & dosage Phospholipases A/metabolism Phospholipases A2 Platelet-Derived Growth Factor/pharmacology Prostaglandin-Endoperoxide Synthases/metabolism Proteins/metabolism Synovial Membrane/cytology
Chemicals
Interleukin-1 Platelet-Derived Growth Factor Proteins phospholipase A2-activating protein Fibroblast Growth Factor 2 Prostaglandin-Endoperoxide Synthases Phospholipases A Phospholipases A2 Dinoprostone
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Goddard D H
Department of Medicine, Winthrop-University Hospital, Mineola, NY 11501.
Grossman S L
Newton R
Clark M A
Bomalaski J S
Article Info
Journal
Cytokine
Abbr.
Cytokine
ISSN
1043-4666
Published
1992-09-00
Pages
377-84
Language
English
Region
England
NLM ID
9005353
Subset
IM
Grants
NIAMS NIH HHS · AR 39382 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]